Cambridge Biosafety Committee Meeting

Description

The Cambridge Biosafety Committee meets on a monthly basis so that members may conduct its oversight activities as granted under the Cambridge Recombinant DNA Technology Ordinance (Chapter 8.20) and the Cambridge Biosafety Regulation of 2009. 

AGENDA

Cambridge Biosafety Committee

Thursday, December 21^st, 2017 – 3:00 pm

119 Windsor Street

Introductions

Presentations

• Gemini Therapeutics (Adarsha Koirala) will present a request for a new BSL-1 permit for their proposed facility at 200 CambridgePark Drive, 2nd Floor.

• UPDATE: Ragon Institute/Partners will present overview of pending work with infectious, Risk Group 3 agents (Ted Myatt, Lee Gehrke)

Old Business/Site visits

11/27 – Quintara Bioscience (625 Mount Auburn Street) – new BSL-1 permit

12/1 – Casebia Therapeutics (610 Main Street, 5^th Floor) – new BSL-1/BSL-2 permit

12/7 – Arbor Biotechnologies (790 Memorial Drive, 2^nd Floor) – new BSL-2 ONLY permit

12/14 – Follow-up to Fulcrum Therapeutics compliance inspection on 10/31/2017

New Business

Adjourn

Remaining Meeting Schedule for 2018 (maintaining 3rd Thursday, 3:00 p.m.). 

January 18     3:00 p.m.
February 15    3:00 p.m.
March 15       3:00 p.m.
April 19       3:00 p.m.
May 17         3:00 p.m.
June 21        3:00 p.m.